Independent Panel to Evaluate Widely
Used Chemical, Bisphenol A
An independent panel of 15 scientists convened
by the Center for the Evaluation of Risks to Human Reproduction
(CERHR), of the NIEHS and National Toxicology Program,
will review recent scientific data and reach conclusions
regarding whether or not exposure to a commonly used chemical,
Bisphenol A (BPA) is hazardous to human development or
Details about the meeting, including panelists and agenda,
are posted on the NTP website http://cerhr.niehs.nih.gov/news/fedreg/fr-12-12-06.pdf
|| March 5, 8:30 a.m. — 5:00 p.m. (Time
is set aside on March 5th for oral public comments, limited
to seven minutes per speaker or organization)
March 6, 8:00 a.m. — 5:00 p.m.
March 7, 8:00 a.m.— noon
Press Availability: Immediately following
the meeting on Wednesday, March 7, 2006 at approximately
12:30. The expert panel meeting may end earlier or later
than 12:00, depending on when the panel completes its deliberations.
At the meeting, the expert panel will review and revise
the draft expert panel report on BPA available at BPA Draft
Report (http://cerhr.niehs.nih.gov/chemicals/bisphenol/Bispehnol_A_Draft_Report.pdf )
and write its summary, conclusions and critical data needs.
The 2.5 day scientific meeting is open to members of the
public and the media.
|| Washington Ballroom
Radisson Hotel Old Town
901 N. Fairfax Street,
Alexandria VA 22314-1501, USA
Tel: (703) 683-6000
Fax: (703) 683-7597
Bisphenol A (BPA) is a high production
volume chemical used in the production of polycarbonate
plastic and several types of resins. Polycarbonate plastics
are widely used in a variety of products including food
and drink containers, CDs, DVDs, electrical and electronic
equipment, automobiles, sports safety equipment. Resins
are used as a protective lining in metal food and drink
containers and water supply pipes. In vitro and animal
data indicate that BPA may mimic the natural female sex
hormone, estradiol. Exposure to the general population
can occur through direct contact to BPA or by exposure
to food or drink that has been in contact with material
The Center for the Evaluation of Risks to Human Reproduction
(CERHR) selected this compound for evaluation because of
its high volume of production, widespread human exposure,
evidence of reproductive toxicity in animal studies, and
public interest and concern.
||The Center for the Evaluation of Risks to Human
Reproduction (CERHR) was established by the National Institute
of Environmental Health Sciences (NIEHS) as part of the National
Toxicology Program in 1998. Michael Shelby, Ph.D., serves as
the CERHR Director. CERHR convenes a scientific expert panel
that meets in a public forum to review, discuss, and evaluate
the scientific literature on a selected chemical. CERHR selects
chemicals for evaluation based upon several factors including
production volume, extent of human exposure, public concern,
and the extent of published information from reproductive and
developmental toxicity studies. The NTP is a DHHS program established
in 1978. It is headquartered at the NIEHS, a part of the National
Institutes of Health. The NIEHS Director, David A. Schwartz,
M.D., serves as the NTP Director.
||No registration is required. Members of the
media interested in attending the press availability immediately
following the meeting or arranging on-site or phone interviews
with the panel Chair or with CERHR staff, please contact Robin
Mackar at (919) 541-0073 or by email at firstname.lastname@example.org.
The National Institute of Environmental Health Sciences (NIEHS), a component
of the National Institutes of Health, supports research to understand
the effects of the environment on human health. For more information
on environmental health topics, please visit our website at http://www.niehs.nih.gov/.
The National Institutes of Health (NIH) — The Nation's Medical
Research Agency — includes 27 Institutes and Centers and
is a component of the U.S. Department of Health and Human Services.
It is the primary federal agency for conducting and supporting basic,
clinical and translational medical research, and it investigates the
causes, treatments, and cures for both common and rare diseases. For
more information about NIH and its programs, visit www.nih.gov.